Clinical Potential of Matrix Metalloprotease Inhibitors in Cancer Therapy

ISSN： 0012-6667

Source： Drugs, Vol.59, Iss.5, 2000-05, pp. : 1043-1055

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Therapeutic potential of matrix metalloprotease inhibitors in neuropathic pain

By Dev Rishabh Srivastava Punit Kumar Iyer Jitesh P Dastidar Sunanda G Ray Abhijit

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 4, 2010-04 ,pp. : 455-468

Informa Healthcare

Access to resources Recommend Favorite

The potential of proteasome inhibitors in cancer therapy

By Sterz Jan Metzler Ivana von Hahne Jens-Claus Lamottke Britta Rademacher Jessica Heider Ulrike Terpos Evangelos Sezer Orhan

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 6, 2008-06 ,pp. : 879-895

Informa Healthcare

Access to resources Recommend Favorite

The Clinical Potential of Matrix Metalloproteinase Inhibitors in the Rheumatic Disorders

By Elliott S. Cawston T.

Drugs & Aging, Vol. 18, Iss. 2, 2001-02 ,pp. : 87-99

Adis International

Access to resources Recommend Favorite

Deubiquitinating Enzyme Inhibitors and their Potential in Cancer Therapy

Current Cancer Drug Targets, Vol. 14, Iss. 6, 2014-07 ,pp. : 506-516

Bentham Science Publishers

Access to resources Recommend Favorite

Future potential of thymidylate synthase inhibitors in cancer therapy

By Lehman Norman L

Expert Opinion on Investigational Drugs, Vol. 11, Iss. 12, 2002-12 ,pp. : 1775-1787

Informa Healthcare

Access to resources Recommend Favorite